Dodla Dairy Q2 Review - Strong Topline Growth Sustains Across Businesses; Outlook Reaffirmed: Systematix

The brokerage believes a premium multiple is achievable given increased confidence on growth, structurally higher margins etc.

Range of Dodla Dairy Ltd.'s product. (Source: Company website)

NDTV Profit’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer NDTV Profit’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.

Systematix Research Report

Dodla Dairy Ltd.’s Q2 FY25 results with revenue/Ebitda/profit after tax growth of 30%/37%/45% YoY were ahead of our high expectations, led by strong performance from the Africa and Orgafeed subsidiaries (which have seen recent capacity additions) coupled with strong uptick in value-added products sales which now make up ~38% of revenue.

Revenue growth was supported by growth in VAP sales (93% YoY) and international business (81% YoY). On consolidated basis, milk sales volumes were up by 6% YoY and procurement volumes were up 1% YoY, indicating some inventory drawdown during the quarter.

Management stated that with the flush season coming to an end, there would be further inventory drawdown going forward, but the company will maintain its strategy of aggressive milk procurement to keep fat/SMP reserves.

It expects procurement costs to remain stable nearterm. Gross margin contracted by 135 bps YoY to 25.5% due to an increase in milk procurement costs in Africa (which has now reversed) and higher volume sales of butter and SMP (lower-margin) in the VAP segment.

Dodla currently has sufficient inventory for the remainder of the year. Ebitda margin improved 50bps YoY to 9.6% despite higher other expenses (+16% YoY) and employee cost (+17% YoY) mainly on account of capacity expansion in Kenya and Orgafeed businesses. PBT and PAT grew 45% YoY.

Click on the attachment to read the full report:

Systematix Dodla Dairy Ltd Q2 FY25 Results Review.pdf
Read Document

Also Read: Indoco Remedies Q2 Results Review - Weak Quarter Led By Lower U.S. Sales: PL Capital

DISCLAIMER

This report is authored by an external party. NDTV Profit does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of NDTV Profit.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

lock-gif
To continue reading this story
Subscribe to unlock & enjoy all
Members-only benefits
Still Not convinced ?  Know More
Watch LIVE TV , Get Stock Market Updates, Top Business , IPO and Latest News on NDTV Profit.
GET REGULAR UPDATES